Gene therapy of glioblastomas: From suicide to homicide

Progress in Brain Research

Volumn 132, Issue , 2001, Pages 711-719

  Tunici, Patrizia ^a   Gianni, Davide ^a   Finocchiaro, Gaetano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; THYMIDINE KINASE;

ANGIOGENESIS; CLINICAL TRIAL; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUICIDE GENE; TUMOR SUPPRESSOR GENE;

ANGIOGENESIS INHIBITORS; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; IMMUNOTHERAPY; PROTEINS; TRANSDUCTION, GENETIC;

EID: 0035783770     PISSN: 00796123     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0079-6123(01)32112-X     Document Type: Article

References (95)

1. Aghi, M., Kramm, C.M., Chou, T.C., Breakefield, X.O. and Chiocca, E.A. (1998) Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies [see comments]. J. Natl. Cancer Inst., 90: 370-380.
2. Albright, L., Madigan, J.C., Gaston, M.R. and Houchens, D.P. (1975) Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guerin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Cancer Res., 35: 658-665.
3. Albright, A.L., Gill III, T.J. and Geyer, S.J. (1977a) Immunogenetic control of brain tumor growth in rats. Cancer Res., 37: 2512-2521.
4. Albright, L., Seab, J.A. and Ommaya, A.K. (1977b) Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients. Cancer, 39: 1331-1336.
5. Ambar, B.B., Frei, K., Malipiero, U., Morelli, A.E., Castro, M.G., Lowenstein, P.R. and Fontana, A. (1999) Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Hum. Gene Ther., 10: 1641-1648.
6. Barba, D., Hardin, J., Ray, J. and Gage, F.H. (1993) Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg., 79: 729-735.
7. Benedetti, S., Dimeco, F., Pollo, B., Cirenei, N., Colombo, B.M., Bruzzone, M.G., Cattaneo, E., Vescovi, A., Didonato, S., Colombo, M.P. and Finocchiaro, G. (1997) Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Hum. Gene Ther., 8: 1345-1353.
8. Benedetti, S., Di Meco, F., Cirenei, N., Bruzzone, M.G., Pollo, B., Florio, N., Caposio, L., Colombo, M.P., Cattaneo, E. and Finocchiaro, G. (1998) IL-4 gene transfer for the treatment of experimental gliomas. Adv. Exp. Med. Biol., 451: 315-321.
9. Benedetti, S., Bruzzone, M.G., Pollo, B., DiMeco, F., Magrassi, L., Pirola, B., Cirenei, N., Colombo, M.P. and Finocchiaro, G. (1999) Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. Cancer Res., 59: 645-652.
10. Benedetti, S., Pirola, B., Pollo, B., Magrassi, L., Bruzzone, M.G., Rigamonti, D., Galli, R., Selleri, S., Di Meco, F., De Fraja, C., Vescovi, A., Cattaneo, E. and Finocchiaro, G. (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med., 6: 447-450.
11. Boviatsis, E.J., Chase, M., Wei, M.X., Tamiya, T., Hurford Jr., R.K., Kowall, N.W., Tepper, R.I., Breakefield, X.O. and Chiocca, E.A. (1994a) Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther., 5: 183-191.
12. Boviatsis, E.J., Park, J.S., Sena-Esteves, M., Kramm, C.M., Chase, M., Efird, J.T., Wei, M.X., Breakefield, X.O. and Chiocca, E.A. (1994b) Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res., 54: 5745-5751.
13. Boviatsis, E.J., Scharf, J.M., Chase, M., Harrington, K., Kowall, N.W., Breakefield, X.O. and Chiocca, E.A. (1994c) Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther., 1: 323-331.
14. Broaddus, W.C., Liu, Y., Steele, L.L., Gillies, G.T., Lin, P.S., Loudon, W.G., Valerie, K., Schmidt-Ullrich, R.K. and Fillmore, H.L. (1999) Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction. J. Neurosurg., 91: 997-1004.
15. Cartmell, T., Southgate, T., Rees, G.S., Castro, M.G., Lowenstein, P.R. and Luheshi, G.N. (1999) Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J. Neurosci., 19: 1517-1523.
16. Chen, S.H., Shine, H.D., Goodman, J.C., Grossman, R.G. and Woo, S.L. (1994) Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057.
17. Cheney, I.W., Johnson, D.E., Vaillancourt, M.T., Avanzini, J., Morimoto, A., Demers, G.W., Wills, K.N., Shabram, P.W., Bolen, J.B., Tavtigian, S.V. and Bookstein, R. (1998) Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res., 58: 2331-2334.
18. Chintala, S.K., Fueyo, J., Gomez-Manzano, C., Venkaiah, B., Bjerkvig, R., Yung, W.K., Sawaya, R., Kyritsis, A.P. and Rao, J.S. (1997) Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene, 15: 2049-2057.
19. Cirenei, N., Colombo, B.M., Mesnil, M., Benedetti, S., Yamasaki, H. and Finocchiaro, G. (1998) In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy. Gene Ther., 5: 1221-1226.
20. Cirielli, C., Inyaku, K., Capogrossi, M.C., Yuan, X. and Williams, J.A. (1999) Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma. J. Neurooncol., 43: 99-108.
21. Cool, V., Pirotte, B., Gerard, C., Dargent, J.L., Baudson, N., Levivier, M., Goldman, S., Hildebrand, J., Brotchi, J. and Velu, T. (1996) Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum. Gene Ther., 7: 627-635.
22. Cowsill, C., Southgate, T.D., Morrissey, G., Dewey, R.A., Morelli, A.E., Maleniak, T.C., Forrest, Z., Klatzmann, D., Wilkinson, G.W., Lowenstein, P.R. and Castro, M.G. (2000) Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: Reduced cytotoxicity of a truncated HSV1-TK. Gene Ther., 7: 679-685.
23. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. and Blaese, R.M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256: 1550-1552.
24. Dawson, D.W., Volpert, O.V., Gillis, P., Crawford, S.E., Xu, H., Benedict, W. and Bouck, N.P. (1999) Pigment epitheliumderived factor: A potent inhibitor of angiogenesis. Science, 285:245-248.
25. Desbaillets, I., Diserens, A.C., de Tribolet, N., Hamou, M.F. and Van Meir, E.G. (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene, 18: 1447-1456.
26. Dewey, R.A., Morrissey, G., Cowsill, C.M., Stone, D., Bolognani, F., Dodd, N.J., Southgate, T.D., Klatzmann, D., Lassmann, H., Castro, M.G. and Lowenstein, P.R. (1999) Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nat. Med., 5: 1256-1263.
27. Dilber, M.S., Abedi, M.R., Christensson, B., Bjorkstrand, B., Kidder, G.M., Naus, C.C., Gahrton, G. and Smith, C.I. (1997) Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res., 57: 1523-1528.
28. DiMeco, F., Rhines, L.D., Hanes, J., Tyler, B.M., Brat, D., Torchiana, E., Guarnieri, M., Colombo, M.P., Pardoll, D.M., Finocchiaro, G., Brem, H. and Olivi, A. (2000) Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. J. Neurosurg., 92: 419-427.
29. Dong, Y., Wen, P., Manome, Y., Parr, M., Hirshowitz, A., Chen, L., Hirschowitz, E.A., Crystal, R., Weichselbaum, R., Kufe, D.W. and Fine, H.A. (1996) In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther., 7: 713-720.
30. Ezzeddine, Z.D., Martuza, R.L., Platika, D., Short, M.P., Malick, A., Choi, B. and Breakefield, X.O. (1991) Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol., 3: 608-614.
31. Fueyo, J., Gomez-Manzano, C., Yung, W.K., Clayman, G.L., Liu, T.J., Bruner, J., Levin, V.A. and Kyritsis, A.P. (1996) Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene, 12: 103-110.
32. Ge, K., Xu, L., Zheng, Z., Xu, D., Sun, L. and Liu, X. (1997) Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine. Int. J. Cancer, 71: 675-679.
33. Geng, L., Walter, S., Melian, E. and Vaughan, A.T. (1998) Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity. Radiat. Res., 150: 31-37.
34. Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P. and Lu, H. (1998) Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA, 95: 6367-6372.
35. Hamel, W., Magnelli, L., Chiarugi, V.P. and Israel, M.A. (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res., 56: 2697-2702.
36. Hanahan, D., Bergers, G. and Bergsland, E. (2000) Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [comment]. J. Clin. Invest., 105: 1045-1047.
37. Harada, H., Nakagawa, K., Iwata, S., Saito, M., Kumon, Y., Sakaki, S., Sato, K. and Hamada, K. (1999) Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Res., 59: 3783-3789.
38. Herrlinger, U., Kramm, C.M., Johnston, K.M., Louis, D.N., Finkelstein, D., Reznikoff, G., Dranoff, G., Breakefield, X.O. and Yu, J.S. (1997) Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther., 4: 345-352.
39. Hsu, S.C., Volpert, O.V., Steck, P.A., Mikkelsen, T., Polverini, P.J., Rao, S., Chou, P. and Bouck, N.P. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res., 56: 5684-5691.
40. Ichikawa, T., Tamiya, T., Adachi, Y., Ono, Y., Matsumoto, K., Furuta, T., Yoshida, Y., Hamada, H. and Ohmoto, T. (2000) In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther., 7: 74-82.
41. Im, S.A., Gomez-Manzano, C., Fueyo, J., Liu, T.J., Ke, L.D., Kim, J.S., Lee, H.Y., Steck, P.A., Kyritsis, A.P. and Yung, W.K. (1999) Antiangiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res., 59: 895-900.
42. Joki, T., Kikuchi, T., Akasaki, Y., Saitoh, S., Abe, T. and Ohno, T. (1999) Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Int. J. Cancer, 82: 714-720.
43. Kanno, H., Hattori, S., Sato, H., Murata, H., Huang, F.H., Hayashi, A., Suzuki, N., Yamamoto, I., Kawamoto, S., Minami, M., Miyatake, S., Shuin, T. and Kaplitt, M.G. (1999) Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma. Cancer Gene Ther., 6: 147-154.
44. Kock, H., Harris, M.P., Anderson, S.C., Machemer, T., Hancock, W., Sutjipto, S., Wills, K.N., Gregory, R.J., Shepard, H.M., Westphal, M. and Maneval, D.C. (1996) Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer, 67: 808-815.
45. Lang, F.F., Yung, W.K., Raju, U., Libunao, F., Terry, N.H. and Tofilon, P.J. (1998) Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. J. Neurosurg., 89: 125-132.
46. Lang, F.F., Yang, W.K., Sawaya, R. and Tofilon, P.J. (1999) Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery, 45: 1093-1104.
47. Liau, L.M., Black, K.L., Prins, R.M., Sykes, S.N., DiPatre, P.L., Cloughesy, T.F., Becker, D.P. and Bronstein, J.M. (1999) Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J. Neurosurg., 90: 1115-1124.
48. Machein, M.R., Risau, W. and Plate, K.H. (1999) Antiangiogenic gene therapy in a rat glioma model using a dominant- negative vascular endothelial growth factor receptor 2. Hum. Gene Ther., 10: 1117-1128.
49. Mahaley Jr., M.S., Aronin, P.A., Michael, A.J. and Bigner, D. (1983a) Prevention of glioma induction in rats by simultaneous intracerebral inoculation of avian sarcoma virus plus bacillus Calmette-Guerin cell-wall preparation. Surg. Neurol., 19: 453-455.
50. Mahaley Jr., M.S., Bigner, D.D., Dudka, L.F., Wilds, P.R., Williams, D.H., Bouldin, T.W., Whitaker, J.N. and Bynum, J.M. (1983b) Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: A pilot study. J. Neurosurg., 59: 201-207.
51. Mahaley Jr., M.S., Gillespie, G.Y., Gillespie, R.P., Watkins, P.J., Bigner, D.D., Wikstrand, C.J., MacQueen, J.M. and Sanfilippo, F. (1983c) Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas. J. Neurosurg., 59: 208-216.
52. Markert, J.M., Malick, A., Coen, D.M. and Martuza, R.L. (1993) Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery, 32: 597-603.
53. Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.L. and Coen, D.M. (1991) Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science, 252: 854-856.
54. Mineta, T., Markert, J.M., Takamiya, Y., Coen, D.M., Rabkin, S.D. and Martuza, R.L. (1994a) CNS tumor therapy by attenuated herpes simplex viruses. Gene Ther., 1: S78.
55. Mineta, T., Rabkin, S.D. and Martuza, R.L. (1994b) Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res., 54: 3963-3966.
56. Mineta, T., Rabkin, S.D., Yazaki, T., Hunter, W.D. and Martuza, R.L. (1995) Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med., 1: 938-943.
57. Miyatake, S., Nishihara, K., Kikuchi, H., Yamashita, J., Namba, Y., Hanaoka, M. and Watanabe, Y. (1990) Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene. J. Natl. Cancer Inst., 82: 217-220.
58. Mizuno, M. and Yoshida, J. (1998) Improvement of transduction efficiency of recombinant adeno-associated virus vector by entrapment in multilamellar liposomes. Jpn. J. Cancer Res., 89: 352-354.
59. Mizuno, M., Yoshida, J., Colosi, P. and Kurtzman, G. (1998) Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration. Jpn. J. Cancer Res., 89: 76-80.
60. Naldini, L., Blomer, U., Gage, F.H., Trono, D. and Verma, I.M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA, 93: 11382-11388.
61. Namba, H., Tagawa, M., Iwadate, Y., Kimura, M., Sueyoshi, K. and Sakiyama, S. (1998) Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells [see comments]. Hum. Gene Ther., 9: 5-11.
62. Okada, H., Miyamura, K., Itoh, T., Hagiwara, M., Wakabayashi, T., Mizuno, M., Colosi, P., Kurtzman, G. and Yoshida, J. (1996) Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther., 3: 957-964.
63. Ono, Y., Ikeda, K., Wei, M.X., Harsh, G.R.t., Tamiya, T. and Chiocca, E.A. (1997) Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy. Hum. Gene Ther., 8: 2043-2055.
64. Palu, G., Cavaggioni, A., Calvi, P., Franchin, E., Pizzato, M., Boschetto, R., Parolin, C., Chilosi, M., Ferrini, S., Zanusso, A. and Colombo, F. (1999) Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: A pilot study in humans. Gene Ther., 6: 330-337.
65. Parker, J.N., Gillespie, G.Y., Love, C.E., Randall, S., Whitley, R.J. and Markert, J.M. (2000) From the cover: Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc. Natl. Acad. Sci. USA, 97: 2208-2213.
66. Parney, I.F., Petruk, K.C., Zhang, C., Farr-Jones, M., Sykes, D.B. and Chang, L.J. (1997) Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model. Hum. Gene Ther., 8: 1073-1085.
67. Parney, I.F., Farr-Jones, M.A., Chang, L.J. and Petruk, K.C. (2000) Human glioma immunobiology in vitro: Implications for immunogene therapy. Neurosurgery, 46: 1169-1177; discussion 1177-1178.
68. Perez-Cruet, M.J., Trask, T.W., Chen, S.H., Goodman, J.C., Woo, S.L., Grossman, R.G. and Shine, H.D. (1994) Adenovirusmediated gene therapy of experimental gliomas. J. Neurosci. Res., 39: 506-511.
69. Rainov, N.G., Kramm, C.M., Aboody-Guterman, K., Chase, M., Ueki, K., Louis, D.N., Harsh, G.R.t., Chiocca, A. and Breakefield, X.O. (1996) Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virusthymidine kinase/ganciclovir paradigm. Cancer Gene Ther., 3: 99-106.
70. Ram, Z., Culver, K.W., Walbridge, S., Blaese, R.M. and Oldfield, E.H. (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats [see comments]. Cancer Res., 53: 83-88.
71. Ram, Z., Walbridge, S., Heiss, J.D., Culver, K.W., Blaese, R.M. and Oldfield, E.H. (1994a) In vivo transfer of the human interleukin-2 gene: Negative tumoricidal results in experimental brain tumors. J. Neurosurg., 80: 535-540.
72. Ram, Z., Walbridge, S., Shawker, T., Culver, K.W., Blaese, R.M. and Oldfield, E.H. (1994b) The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg., 81: 256-260.
73. Rogulski, K.R., Kim, J.H., Kim, S.H. and Freytag, S.O. (1997) Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther., 8: 73-85.
74. Saleh, M., Stacker, S.A. and Wilks, A.F. (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401.
75. Saleh, M., Wiegmans, A., Malone, Q., Stylli, S.S. and Kaye, A.H. (1999) Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors. J. Natl. Cancer Inst., 91: 438-445.
76. Sasaki, M., Wizigmann-Voos, S., Risau, W. and Plate, K.H. (1999) Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas. Int. J. Dev. Neurosci., 17: 579-591.
77. Shewach, D.S., Zerbe, L.K., Hughes, T.L., Roessler, B.J., Breakefield, X.O. and Davidson, B.L. (1994) Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther., 1: 107-112.
78. Sobol, R.E., Fakhrai, H., Shawler, D., Gjerset, R., Dorigo, O., Carson, C., Khaleghi, T., Koziol, J., Shiftan, T.A. and Royston, I. (1995) Interleukin-2 gene therapy in a patient with glioblastoma. Gene Ther., 2: 164-167.
79. Sturtz, F.G., Waddell, K., Shulok, J., Chen, X., Caruso, M., Sanson, M., Snodgrass, H.R. and Platika, D. (1997) Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: Implications for gene therapy. Hum. Gene Ther., 8: 1945-1953.
80. Sugita, Y., Becerra, S.P., Chader, G.J. and Schwartz, J.P. (1997) Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J. Neurosci. Res., 49: 710-718.
81. Takamiya, Y., Short, M.P., Ezzeddine, Z.D., Moolten, F.L., Breakefield, X.O. and Martuza, R.L. (1992) Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res., 33: 493-503.
82. Takamiya, Y., Short, M.P., Moolten, F.L., Fleet, C., Mineta, T., Breakefield, X.O. and Martuza, R.L. (1993) An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg., 79: 104-110.
83. Tamiya, T., Ono, Y., Wei, M.X., Mroz, P.J., Moolten, F.L. and Chiocca, E.A. (1996) Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6- thioxanthine or 6-thioguanine. Cancer Gene Ther., 3: 155-162.
84. Tanaka, T., Cao, Y., Folkman, J. and Fine, H.A. (1998) Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res., 58: 3362-3369.
85. Thomas, C.E., Schiedner, G., Kochanek, S., Castro, M.G. and Lowenstein, P.R. (2000) Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long- term neurological gene therapy for chronic diseases [In Process Citation]. Proc. Natl. Acad. Sci. USA, 97: 7482-7487.
86. Tjuvajev, J., Gansbacher, B., Desai, R., Beattie, B., Kaplitt, M., Matei, C., Koutcher, J., Gilboa, E. and Blasberg, R. (1995) RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma. Cancer Res., 55: 1902-1910.
87. Tseng, S.H., Hwang, L.H. and Lin, S.M. (1997) Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines. J. ImmunoTher., 20: 334-342.
88. Tseng, S.H., Hsieh, C.L., Lin, S.M. and Hwang, L.H. (1999) Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain. Cancer Gene Ther., 6: 302-312.
89. Vincent, A.J., Vogels, R., Someren, G.V., Esandi, M.C., Noteboom, J.L., Avezaat, C.J., Vecht, C., Bekkum, D.W., Valerio, D., Bout, A. and Hoogerbrugge, P.M. (1996) Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum. Gene Ther., 7: 197-205.
90. Visse, E., Siesjo, P., Widegren, B. and Sjogren, H.O. (1999) Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1- transfected tumor cells. Cancer Gene Ther., 6: 37-44.
91. Wang, Z.H., Zagzag, D., Zeng, B. and Kolodny, E.H. (1999) In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha. J. Neuropathol. Exp. Neurol., 58: 847-858.
92. Weller, M., Malipiero, U., Rensing-Ehl, A., Barr, P.J. and Fontana, A. (1995) Fas/APO-1 gene transfer for human malignant glioma. Cancer Res., 55: 2936-2944.
93. Wikstrand, C.J. and Bigner, D.D. (1981) Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction. J. Neuroimmunol., 1: 249-260.
94. Yamanaka, R., Tanaka, R., Yoshida, S., Saitoh, T. and Fujita, K. (1995) Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. J. Neurooncol., 25: 59-65.
95. Yu, J.S., Burwick, J.A., Dranoff, G. and Breakefield, X.O. (1997) Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum. Gene Ther., 8: 1065-1072.